Long-term Persistence Study to Assess a Booster Dose of GSK Biologicals' Hib-MenC

NCT00322335 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilus Influenzae Type b
Neisseria Meningitidis

Interventions

BIOLOGICAL: Haemophilus influenzae type b- and meningococcal (vaccine)
BIOLOGICAL: Infanrix™ penta
BIOLOGICAL: Infanrix™ hexa
BIOLOGICAL: Engerix-B
BIOLOGICAL: NeisVac-C™
BIOLOGICAL: Infanrix™ IPV/HIB
BIOLOGICAL: Meningitec™

Sponsor

GlaxoSmithKline